Lee HA, Imran M, Monteiro-Riviere NA, Colvin VL, Yu WW, Riviere JE. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Letters. 2007 Sep;7(9):2865-70. doi: 10.1021/nl071563c.

Tannenbaum S, Holford NHG, Lee H, Peck C, Mould DR. Simulation of Correlated Continuous and Categorical Variables using a Single Multivariate Distribution. Journal of Pharmacokinetics and Pharmacodynamics, 2006 Dec;33(6):773-94.

Lee H. Chapter 1. Disappearance of Biomedical Science, Destruction of Research Ethics. In: Hwang Woo Suk’s Scandal. Hannarae Publishing Co., Seoul, Korea (ISBN : 9788955660487)

Knollmann BC, Smyth B, Garnett C, Salessiotis A, Gvodjan D, Berry NS, Lee H, Min FD. Personal Digital Assistant-Based Drug Reference Software as Tools to Improve Rational Prescribing: Benchmark Criteria and Performance.Clin Pharmacol Ther 2005 Jul;78(1):7-18.

Lee H, Yim D-S, Zhou H, Peck CC. Evidence of Effectiveness: How Much Can We Extrapolate From Existing Studies? AAPS Journal.  2005 Oct 5;7(2):E467-74.

Lack NA, Green B, Dale DC, Calandra GB, Lee H, MacFarland RT, Badel K, Liles WC, Bridger G, A Pharmacokinetic/Pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, Clin Pharmacol Ther 2005;77(5): 427-36.

Yim DS, Zhou H, Buckwalter M, Nestorov I, Peck CC, Lee H. Population Pharmacokinetic Analysis and Simulation of the Time Concentration Profile of Etanercept in Pediatric Patients with Juvenile Rheumatoid Arthritis, Journal of Clinical Pharmacology, 2005;45(3):246-256.

Lee H. Good Review Practices are the first step forward for the Korea Food and Drug Administration, Drug Information Journal 2005;39: 185-192.

Lee H. FDA vs. KFDA. The Young Physicians Press. Seoul, Korea, 2005 (ISBN : 8991232043)

Lee H, Kimko H, Rogge M, Wang D, Nestorov I, Peck CC. Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther 2003;73(4): 348-365.

Cross J, Lee H, Westelinck A, Nelson J, Grudzinskas C, Peck C. Postmarketing Drug Dosage Changes of 499 FDA-Approved New Molecular Entities, 1980-1999, Pharmacoepidemiology and Drug Safety, 2002;11:439-446.

Lee H, Application of foreign clinical trial data by using pharmacokinetic-pharmacodynamic modeling and simulation technique in Korea: a regulatory point of view. Kor J Clin Pharmacol Ther, 2002; 10(2): 193-9.